StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. It also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Carson City, Nevada.
Frequently asked questions
What sector does CMXCD (CMXCD) operate in?
CMXCD belongs to the Other sector and operates in the Medical Devices industry.
What is CMXCD (CMXCD) current stock price?
As of the latest data, CMXCD stock price is $0.48, with a previous close of $0.48.
What is CMXCD (CMXCD) current market capitalization?
CMXCD market cap is approximately 9.57 million.
Does CMXCD (CMXCD) pay dividends?
No. CMXCD does not pay a dividend.
What is CMXCD (CMXCD) beta (volatility) score?
CMXCD has a beta of 21.656, indicating very high volatility compared to the market.